EZH2 and Miyoshi myopathy: Recently, we provided evidence that pharmacological EZH2 inhibition using UNC1999 exerts anti-MM effects by reducing the levels of H3K27me3 and de-repression of bivalent genes involved in tumor suppressor functions such as apoptosis and cellular differentiation [23].